© 2026 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions | Cookies

Health and Biotech

Top Section/Ad

Top Section/Ad

Most recent

High grade and crossover bonds

Novonesis lands €1.7bn euro debut at 'minimal concession'

Bagsvaerd, Denmark. 02nd, March 2025. The global biotechnology company Novonesis with its headquarters in Bagsvaerd. The company Novozymes merged with Chr. Hansen to form Novonesis in January 2024.
Diana Bui, March 12, 2026
Equity
Galderma shareholders exit as huge block trade is increased
Arthur Bautzer, March 12, 2026
Equity
Galderma shareholders launch block trade of up to Sfr4.3bn
Arthur Bautzer, March 10, 2026
Equity
MedinCell launches follow-on
Arthur Bautzer, March 05, 2026
High grade and crossover bonds
Abbott takes out M&A whopper amid drugs binge
David Rothnie, February 26, 2026
Syndicated Loans
mental health hospital from alamy .jpg
Healthcare M&A expected to rise as Galaxy Group secures £400m of loans
Eight banks provided loan facility to company
Jennifer Law, February 05, 2026
Health and Biotech
Malaria mosquito from Alamy 15Jan26 575x375.jpg
IFFIm begins review of its future as Lay hands reins to Baker
Vaccine bond programme to issue $1.5bn this year but needs new pledges
Jon Hay, January 19, 2026
ABS US
Doctor or nurse wearing blue surgical gloves holding a double vaccine dose
Vital Care increases medical infusion securitization
First deal of its kind more than 1.5 times subscribed
Chadwick Van Estrop , December 12, 2025
Securitization
Vaccine_AdobeStock_575x375_24Nov20
Vital Care aims for medical infusion-linked WBS first
Deal complexity, new issuer premium sees trade start more than 100bp wide of last WBS
Chadwick Van Estrop , December 04, 2025
More articles/Ad

More articles/Ad

More articles

Load More